Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Sanjiv S. Agarwala, MD
Professor
Temple University School of Medicine
Philadelphia, PA
Authored Items
Benefits of Dual I-O Therapy in Metastatic Uveal Melanoma
By
Sanjiv S. Agarwala, MD
Conference Correspondent
Dual IO 2021 Year in Review
The combination of nivolumab and ipilimumab offers deep and sustained responses and improved overall survival in malignant uveal melanoma.
Read More ›
Dual Immune Checkpoint Inhibitors in Advanced Cutaneous Melanoma
By
Sanjiv S. Agarwala, MD
Conference Correspondent
Dual IO 2021 Year in Review
Dual immunotherapy provides significant and durable benefits as first-line treatment and as neoadjuvant therapy in advanced melanoma.
Read More ›